6008集团官方网站

6008集团官方网站(中国)股份有限公司
Milestones
1999
Milestones
1999
LifeTech Scientific Corporation was established in Shenzhen, China
6008集团官方网站(中国)股份有限公司
2001
Milestones
2001
HeartR? PDA Occluder was approved by NMPA in China, becoming the first product successfully marketed by the company
6008集团官方网站(中国)股份有限公司
2003
Milestones
2003
HeartR? ASD Occluder was approved by NMPA in China
6008集团官方网站(中国)股份有限公司
2004
Milestones
2004
Ankura? TAA\AAA Stent Graft System and HeartR? VSD Occluder were approved by NMPA in China
6008集团官方网站(中国)股份有限公司
2005
Milestones
2005
Aegisy? Vena Cava Filter was approved by NMPA in China
6008集团官方网站(中国)股份有限公司
2006
Milestones
2006
SteerEase? Introducer was approved by NMPA in China
6008集团官方网站(中国)股份有限公司
2008
Milestones
2008
The company was accredited as a national high-tech enterprise in China
The company expanded its business into India market and incorporated Lifetech Scientific India Private Limited into the LifeTech family
6008集团官方网站(中国)股份有限公司
2009
Milestones
2009
Aegisy? Vena Cava Filter obtained the CE mark in EU, becoming the first product of the company to receive one
Cera? Occluder series and SteerEase? Introducer obtained the CE mark in EU
6008集团官方网站(中国)股份有限公司
2010
Milestones
2010
SeQure? Snare System received FDA approval in the United States, becoming the first product of the company to receive one
Fustar? Steerable Introducer, Cera? Vascular Plug System, Acumark? Sizing Balloon, Cera? Multi-Fenestrated ASD Occluder and SeQure? Snare System obtained the CE mark in EU
6008集团官方网站(中国)股份有限公司
2011
Milestones
2011
LifeTech Scientific Corporation was listed on the Hong Kong Stock Exchange (Stock Code: 1302.HK)
The company incorporated LifeTech Scientific (Europe) Co?peratief U.A. to further explore the European market
Fustar? Steerable Introducer received FDA approval in the United States
CeraFlex? Occluder series and Vascular Plugs, Ankura? Stent Graft System obtained the CE mark in EU
6008集团官方网站(中国)股份有限公司
2012
Milestones
2012
The company incorporated LifeTech Scientific (Netherlands) B.V. into the LifeTech family
Cera? PDA Occluder and ASD Occluder were approved by NMPA in China
HeartR? Occluder series, Cera?/CeraFlex?/IrisFit? PFO Occluders and LawMax? Dilator obtained the CE mark in EU
6008集团官方网站(中国)股份有限公司
2013
Milestones
2013
Cera? VSD Occluder was approved by NMPA in China
LawMax? Dilator received FDA approval in the United States
6008集团官方网站(中国)股份有限公司
2014
Milestones
2014
Fustar? Steerable Introducer was approved by NMPA in China
6008集团官方网站(中国)股份有限公司
2015
Milestones
2015
The company has been included in the Hang Seng Index
The company incorporated Lifetech Scientific America Corporation to add to its list of international subsidiaries
6008集团官方网站(中国)股份有限公司
2016
Milestones
2016
The company has been included in the Shenzhen-Hong Kong Stock Connect Programs
The company established a subsidary in Hong Kong and Greece, respectively
LAmbre? LAA Closure System and GoldenFlow? Peripheral Bare Stent System obtained the CE mark in EU
SteerNavi? Introducer was approved by NMPA in China
6008集团官方网站(中国)股份有限公司
2017
Milestones
2017
LAmbre? LAA Closure System, HeartTone? Implantable Cardiac Pacemakers, SeQure? Snare System, LawMax? Dilator and Ankura? II Stent Graft System were approved by NMPA in China
6008集团官方网站(中国)股份有限公司
2018
Milestones
2018
The company established a strategic partnership with Ally Bridge Group, a global life science-focused investment firm
KONAR-MF? VSD Occluder obtained the CE mark in EU
6008集团官方网站(中国)股份有限公司
2019
Milestones
2019
The company incorporated LifeTech Scientific Deutschland GmbH to further expand its business in the heart of Europe
LAmbre? LAA Closure System obtained FDA approval for the pre-market clinical study in the United States
Aelark? Vena Cava Filter System was approved by NMPA in China
6008集团官方网站(中国)股份有限公司
2020
Milestones
2020
LAmbre? LAA Closure System obtained FDA approval for an investigator-initiated pre-market clinical trial in the United States
HeartR? II ASD Occluder, Fustar? mini Steerable Catheter, FiQure? Vena Cava Filter Retrieval System, ZoeTrack? Guidewire, FemCross? 18 Peripheral Balloon Dilatation Catheter, Futhrough? Stent Graft Balloon Catheter were approved by NMPA in China
Futhrough? Endovascular Needle System obtained the CE mark in EU
6008集团官方网站(中国)股份有限公司
2021
Milestones
2021
The invention patent “LAA Occluder” won the WIPO-CNIPA Award for Chinese Outstanding Patented Invention
G-iliac? Iliac Artery Bifurcation Stent Graft System, Yuranos? Abdominal Aortic Stent Graft System, LAxible? LAA Occluder, LAnavi? Jointed Steerable Introducer, OKcurve? Steerable Delivery System, Freepath? Guidance System and iCable? Delivery Cable were approved by NMPA in China
IBS Angel? Iron Bioresorbable Scaffold System obtained registration approval from Malaysian Medical Device Authority (MDA)
Xuper? Open Surgery Stent Graft System obtained the CE mark in EU
6008集团官方网站(中国)股份有限公司
2022
Milestones
2022
An FDA-approved investigator-initiated pre-market clinical trial of LAmbre? Plus LAA Closure System obtained medical insurance coverage in the United States
Fitaya? Vena Cava Filter System, FemCross? 35 Peripheral Balloon Dilatation Catheter and Ankura? llc Stent Graft System were approved by NMPA in China
6008集团官方网站(中国)股份有限公司
2023
Milestones
2023
IBS Angel??Iron Bioresorbable Scaffold System obtained CE MDR certification in EU
Peripheral?Thrombus?Aspiration?Catheter, AcuMark? Sizing Balloon and Epione??Surgical?Navigation?System were approved by NMPA in China
6008集团官方网站(中国)股份有限公司
【网站地图】